C21 · Pharmaceuticals · China

Share of global biopharmaceutical pipeline

China: 30% in 2025.

  • 30% Latest · China · 2025
  • Annual Release cadence
  • 2 Records · 1 region · 2015–2025

Verified 17 Sep 2026 · 1 publisher · Next period 2026

Over time

China over time. Forecasts are dashed with hollow markers; the underlying values are one click away under the chart.

Fig 1 · C21 · China Annual

Share of global biopharmaceutical pipeline

China, 2015 to 2025

2 observations · 2015 to 2025
Share of global biopharmaceutical pipelineShare of global biopharmaceutical pipeline. 2 observations from 2015 to 2025, ranging from 2% to 30%. Latest value 30% (2025). % 0 10 20 30 2015 2017 2019 2021 2023 2025 2% 30%
Share of global biopharmaceutical pipelineShare of global biopharmaceutical pipeline. 2 observations from 2015 to 2025, ranging from 2% to 30%. Latest value 30% (2025). % 0 10 20 30 2015 2017 2019 2021 2023 2025 2% 30%
Share of global biopharmaceutical pipelineShare of global biopharmaceutical pipeline. 2 observations from 2015 to 2025, ranging from 2% to 30%. Latest value 30% (2025). % 0 10 20 30 2015 2017 2019 2021 2023 2025 2% 30%
View the underlying data
Share of global biopharmaceutical pipeline
Period Type Value
2015 Actual 2%
2025 Actual 30%
Source: State Council · percent · CC BY 4.0 · statorigin.org

Every record

2 records · 1 region · 2015–2025. Each period links to its record: the value, its source evidence and original document.

Share of global biopharmaceutical pipeline: every record, grouped by region, newest first.
Period Value Source Type
China 2 records
2025 30% State Council · 31 Dec 2025
2015 2% State Council · 31 Dec 2015

Download this data

Every file carries its provenance: the CSV has a source column per row, and the chart images print the publisher, the licence and this page's address under the drawing. Source: State Council. Licence: CC BY 4.0.

Embed this chart

For automatic sizing and multiple charts, see the JavaScript embed guide.

Free to embed anywhere, including commercially. The attribution bar is part of the chart. The link under the frame is optional: keep it, remove it or mark it rel="nofollow".

<iframe src="https://statorigin.org/embed/pharmaceuticals--share-of-global-biopharmaceutical-pipeline--trend" width="100%" height="380" style="border:1px solid #e2e5e3;border-radius:8px" title="Share of global biopharmaceutical pipeline" loading="lazy"></iframe>
<p><a href="https://statorigin.org/indicators/share-of-global-biopharmaceutical-pipeline">Data: State Council via StatOrigin</a> · CC BY 4.0</p>
Preview embed

Use and publication rights

  • View, cite and link: free

    Quote any number, cite this page or a single record, and link to it anywhere.

  • Copy, chart and republish: free with attribution

    The data is published under CC BY 4.0, commercial use included. Credit StatOrigin and the original publisher (State Council); the chart files already carry that line.

  • The source documents: the publisher's terms

    Figures are facts read from the publishers' own documents. The documents themselves, their text and design, stay under each publisher's terms; follow the source links for those.

How this measure is built

Definition
Proportion of global biopharmaceutical research and development pipeline assets originating from a specific country or region.
Measure
One slice of Medicines in clinical development ( form: share, segment: biopharmaceutical ) . Total number of drug candidates actively evaluated in clinical trials. Region and period are columns on every record, not slices.
Limitations
Values are shown as published; StatOrigin does not revise, fill gaps or convert currencies.
Verification
Each value, unit, period and place was checked against its source evidence before publication. See the methodology and the corrections process.

Sources · 1 document

Document Publisher Published Data points
China to expand health insurance coverage for innovative drugs State Council — 2

Other slices of medicines in clinical development

Frequently asked questions

What is the latest share of global biopharmaceutical pipeline?

China: 30% in 2025.

Where does this data come from?

From 1 document published by State Council. Every figure on this page links to its record, which preserves the original source evidence.

How often is it updated?

Annual. The newest published period is 2025; the next release should cover 2026. A new figure appears here once the publisher releases it and it passes verification.

Can I use this data?

Yes. StatOrigin publishes it under CC BY 4.0: you may copy, chart and republish it, including commercially, with attribution to StatOrigin and to the original publisher.

Cite this page

Cite the page as a data set, or open any record to cite one figure: each record carries APA, MLA, Chicago and BibTeX forms that credit the original publisher.

StatOrigin. (2026). Share of global biopharmaceutical pipeline [Data set]. Retrieved October 28, 2026, from https://statorigin.org/indicators/share-of-global-biopharmaceutical-pipeline

"Share of global biopharmaceutical pipeline." StatOrigin, 2026, https://statorigin.org/indicators/share-of-global-biopharmaceutical-pipeline. Accessed 28 Oct. 2026.

StatOrigin. "Share of global biopharmaceutical pipeline." Data set, 2026. Accessed October 28, 2026. https://statorigin.org/indicators/share-of-global-biopharmaceutical-pipeline.

@misc{statorigin_share_of_global_biopharmaceutical_pipeline_2026, title = {Share of global biopharmaceutical pipeline}, author = {{StatOrigin}}, year = {2026}, url = {https://statorigin.org/indicators/share-of-global-biopharmaceutical-pipeline}, note = {Data set. Accessed 2026-10-28} }